-
Anal Cancer Market Heats Up Following Incyte's Zynyz Greenlight Delveinsight
30 May 2025 00:27 GMT
… on FDA-approved anal cancer drugs @ Anal Cancer Treatment Options
Alongside the … Lilly and Company, RedHill Biopharma, Arena Pharmaceuticals, Mesoblast, among others.
Human Papillomavirus …
-
Crohn's Disease Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
10 Jul 2025 03:19 GMT
… Kang Stem Biotech, Alpha Cancer Technologies, Koutif Therapeutics, Winston … , Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, Priothera, and others. … , Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, Priothera, and others. …
-
Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and Company, Merck Sharp & Dohme LLC, T
02 May 2024 17:00 GMT
… and Colitis-associated colorectal cancer (CACC), necessitating additional … KangStem Biotech, Immunic, Alpha Cancer Technologies, Koutif Therapeutics, Tract … bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, NGM Biopharmaceuticals …
-
DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight
25 Jun 2025 22:36 GMT
… focus on targeted therapies in cancer treatment. Moreover, recent … clinical trials for autoimmune conditions, cancers, and viral infections, reflecting … key ulcerative colitis companies, including Arena Pharmaceuticals, Pfizer, Abivax, Reistone Biopharma, …
-
North America Legal Cannabis Market Report 2022: Featuring 22nd Century, Medical Marijuana Inc, Arena Pharmaceuticals & More - ResearchAndMarkets.com
20 Jan 2023 16:42 GMT
… traumatic stress disorder, social anxiety, cancer, multiple sclerosis and epilepsy. … various diseases such as migraine, cancer, arthritis and others.
Breakup … Marijuana Inc
HempInc
Axim Biotechnologies
Arena Pharmaceuticals Inc
Canopy Growth Corporation
…
-
Regulatory tracker: Lilly's Retevmo secures pediatric cancer FDA nod
03 Jan 2024 17:45 GMT
… small cell lung cancer (NSCLC), melanoma, gastric cancer, colorectal cancer and renal … through its $6.7 billion Arena Pharmaceuticals acquisition. The drug rivals … with urothelial carcinoma, lung cancer, breast cancer and hepatocellular carcinoma. With …
-
Pfizer Buying Arena Pharmaceuticals for $6.7B
13 Dec 2021 17:11 GMT
… to buy San Diego-based Arena Pharmaceuticals (Nasdaq: ARNA) in a $6 … significantly expand Pfizer's cancer and inflammatory disease drug pipeline …
-
Why Arena Pharmaceuticals Stock Is Soaring Today
13 Dec 2021 15:51 GMT
… Munshi, president and CEO of Arena Pharmaceuticals.
"Pfizer’s capabilities will … added.
Related Link: After Blood Cancer, Pfizer Now Bolsters Its Inflammatory … -inflammatory diseases.
ARNA Price Action: Arena Pharmaceuticals has traded as low as …
-
Impilo Therapeutics Launches to Enable Nucleic Acid-Based Medicines to Effectively Treat Solid Tumor Cancers
15 Aug 2023 16:59 GMT
… stroma, composed of non-cancerous cells and extracellular matrix … Ionis, Regulus Therapeutics, and Arena Pharmaceuticals.
"I am thrilled … treatment of solid tumor cancers. The Platform also … effectively-treat-solid-tumor-cancers-301900313.html
SOURCE …
-
Ovarian Cancer Market to Grow Rapidly at a CAGR of 16% by 2030 | DataM Intelligence
04 Aug 2023 15:00 GMT
… the Global Ovarian Cancer Market In May 2023, Arena Pharmaceuticals launched Dostarlimab, an … immunotherapy for the treatment of advanced endometrial cancer …
About
© 1995-2025